189
staff
Christopher Austin
Christopher Austin, MD, is a CEO-partner at Flagship Pioneering in Cambridge, MA, and CEO of Vesa
lius Therapeutics, one of Flagship’s franchise companies that is commercializing a platform to systematically develop treatments for common diseases.
+ Read More
report
New Models for Financing Translational Medical Research in Singapore: Update
Since 2017, the Milken Institute has engaged with stakeholders worldwide on new models for financin
g translational biomedical research in Singapore.
+ Read More
report
Shifting the Retirement Paradigm: Moving toward Lifetime Financial Security
During the past two years, the Milken Institute has focused on how Americans manage lifetime financ
ial security leading to a financially secure retirement.
+ Read More
report
Maternal Mortality Among Vulnerable US Communities
This report covers the alarming reality of maternal mortality in the United States, where the mater
nal mortality ratio (number of maternal deaths per 100,000 births) stands as one of the highest among
+ Read More
report
Best Practices of Sovereign Wealth Funds: The Case for The Philippines
Many nations create sovereign wealth funds (SWFs) to invest surplus assets in a diversified portfol
io approach to achieve national policy goals, hedge against economic risk, and benefit successive generations.
+ Read More
report
Our Shared Responsibility: Technologies Accelerating the Path to Green Financing
In a private roundtable at the 2022 Singapore Fintech Festival, leading technologists, chief sustai
nability officers, large investors, and financial regulators gathered for off-the-record dis
+ Read More
panel
A Conversation with US Senator Bill Hagerty
panel
Video Transition
panel
Video Transition
panel
Video Transition
panel
Video Transition
panel